Geoffrey Glauser

Senior Consultant Supply Chain HHS/ASPR/BARDA
Geoffrey Glauser is currently a subject matter expert in support of the Manufacturing, Facilities, and Engineering Division of the Biomedical Advancement Research Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response (ASPR) within Health and Human Services (HHS).  This division contracts the development, and supply of vaccines, antivirals, diagnostics, therapeutics and ancillary products for Pandemic Influenza, Project BioShield, and research and development Programs.  He is a contributing technical author to the Parenteral Drug Association publications and the International Society for Pharmaceutical Engineering (ISPE). Recently he worked with the Center for Disease Control in Sierra Leone on a Phase 2-3 Ebola vaccine clinical trial.  
Mr. Glauser has previously worked in line and staff positions with Pfizer (Wyeth) Pharmaceuticals in the Global Packaging Technology group supporting biotech, vaccine, and consumer areas with temperature controlled shipping expertise and solutions. In other industrial positions, he has directed supply chain, biological, sterile and chemical planning and manufacturing activities with Merck & Co. Inc. (25 years) and Fisher Clinical Services for in-line, new product and clinical biological and pharmaceutical entities both domestically and internationally.  A former US Navy officer and engineer, Mr. Glauser has a microbiology degree from Indiana University.

March 17, 2021

1:05 PM COLLABORATION in Distribution

COVID 19 has delivered unique pressures to a supply chain that was already regulated by multiple sensitivities. Now, as healthcare systems, pharmacies and other vaccine administrators map out workflows to implement mass vaccination strategies, what distribution models and solutions have proven effective and will break the mold? How are stakeholders addressing the major obstacles in the distribution requirements?